Kabiven (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Kabiven is used to provide amino acid supplementation for patients receiving parenteral nutrition.

• Parenteral nutrition: supports protein synthesis and nitrogen balance in patients unable to receive enteral feeding.
• Post‑operative care: supplies essential amino acids to promote recovery after surgery.
• Critical care: maintains nutritional status in intensive‑care patients with high metabolic demand.

• Kabiven delivers a balanced mixture of essential and non‑essential amino acids directly into the bloodstream. These amino acids are taken up by cells and incorporated into new proteins, supporting tissue repair, immune function, and the maintenance of nitrogen balance. By bypassing the gastrointestinal tract, the solution ensures rapid availability of substrates for protein synthesis in patients who cannot tolerate oral or enteral nutrition.

Kabiven may be associated with several adverse reactions during or after infusion.

Common Side Effects

• Hyperglycemia: elevated blood glucose levels, especially in diabetic patients.
• Electrolyte disturbances: changes in potassium, sodium, or calcium concentrations.
• Infusion site reactions: erythema, pain, or phlebitis at the catheter site.
• Nausea or vomiting: gastrointestinal discomfort during administration.
• Mild metabolic alkalosis: slight increase in blood pH.
• Increased blood urea nitrogen: reflecting nitrogen load.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction with respiratory distress.
• Severe hypernatremia: dangerously high sodium levels.
• Severe metabolic acidosis: significant drop in blood pH.
• Hepatic dysfunction: abnormal liver enzyme elevations.
• Renal failure: worsening kidney function in susceptible patients.
• Thrombophlebitis: clot formation with vein inflammation.

When using Kabiven, clinicians should observe several safety measures.

• Monitor blood glucose: check levels regularly, especially in diabetic patients.
• Monitor electrolytes: assess serum potassium, sodium, calcium, and magnesium.
• Adjust dose in renal or hepatic impairment: reduce infusion rate as needed.
• Use aseptic technique: prevent contamination during preparation and administration.
• Avoid in patients with known hypersensitivity to any component of the solution.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kabiven can interact with other medications that affect electrolyte balance or nitrogen load.

Major Interactions (Avoid)

• Concurrent high‑dose potassium chloride: risk of severe hyperkalemia.
• Co‑administration with other amino acid solutions: may cause excess nitrogen burden.
• Use with certain diuretics (e.g., loop diuretics) without electrolyte monitoring: can precipitate electrolyte shifts.

Moderate Interactions (Monitor Closely)

• Insulin therapy: may require glucose monitoring due to potential hyperglycemia.
• Corticosteroids: can alter protein catabolism and affect nutritional needs.
• Nephrotoxic drugs (e.g., aminoglycosides): monitor renal function closely.